Yervoy (ipilimumab) - Ono Pharma, BMS
lefitolimod (MGN1703) - OncXerna Therap, iPharma, Gilead
"A Phase I clinical trial presented by Dr. Mirella Nardo showed promising results for a combination of lefitolimod and ipilimumab in patients with advanced solid tumors (2564). https://t.co/HTFsDSDKA3 @mirella_nardo @DavidHongMD @ASCO #ASCO23 #immunotherapy #EndCancer (5/9)" (,@MDAndersonNews) Jun 4, 2023 
Clinical • Metastases • Oncology • Solid Tumor
https://twitter.com/MDAndersonNews/status/1665132637080502273
 
Jun 4, 2023
 
 
b21c0e5c-ce69-4984-89d0-a99fd49d9b00.jpg